Dispersion Delivery TRIZ Cases

Vibrating membrane nebulizer produces respirable immunoglobulin aerosols using proline to prevent aggregation and denaturation during delivery.

Peptide compounds bind to the MERS-CoV spike protein receptor binding domain, competitively inhibiting viral interaction with host cell receptors.

Identifies BAP1 and CDKN2A biomarkers to detect cancer cell sensitivity to MDM2 antagonists.

Segmented pellets and buoyant gas generation retain GHB in the stomach, resolving incomplete absorption from rapid transit.

Surfactant-coated iron oxide particles in nanoemulsions boost sensitivity and stability while maintaining patient tolerability.

Surfactants prevent aggregate formation during nebulization, preserving biological activity and achieving a volume median diameter between 1 and 10 μm.

Ultracentrifuged krill oil forms liposomes that attach to intestinal mucosa.

A nasal spray medication using DMSO and hypochlorous acid to deliver rapid symptom relief.

A synergistic neuroprotective composition combines caffeine and long chain fatty acyl tryptamide to reduce α-synuclein phosphorylation.

A fibrous plant product layer treated with a plant extract enables standardized beverage infusion.

Top spray granulation deposits flavoring agents onto polyethylene glycol granules, preventing additive segregation and ensuring consistent dosing accuracy.

Lipid-based nanoparticle compositions enhance solubility and stability of therapeutic agents through phosphatidylcholine formulations.

Modified caveolin-1 peptides modulate uPA, uPAR, and beta1-integrin interactions to treat pulmonary hypertension and lung fibrosis.

Optimizing pH to 5.0-6.0 with xanthan gum prevents degradation impurities in hydroxycarbamide solutions, extending shelf-life at room temperature.

A beverage composition stabilizes oxygen bubbles using surfactants and viscosity modifiers to enhance oral absorption efficiency.

Nitrogen purging creates an inert atmosphere for R-152a charging, eliminating flammability risks while maintaining existing facility compatibility.

Calcium silicate prevents clumping in urea powders, resolving manufacturing issues while maintaining therapeutic effectiveness.

Oral S-isomer of alpha-methyl-hydrocinnamic acid stimulates multi-lineage hematopoietic cell production.

A complex coacervate of lactoferrin and osteopontin stabilizes protein bioactivity for infant formula applications.

Click chemistry links modified MC1R peptide ligands to triblock polymer micelles, preserving nanomolar binding affinity lost when attaching large structures.

Formula I compounds with galloyl moieties inhibit 3CLPro protease activity to treat coronavirus infections.

Acidic buffer formulation stabilizes antibodies during mesh nebulization, preventing aggregation and preserving biological activity.

A functional food composition protects cranial nerves and improves blood flow using a synergistic blend of twelve herbal ingredients.

Intravesical gadolinium-perfluorocarbon emulsion improves bladder wall lesion contrast by masking lumen signals through rapid decay.

Targeted peptide inhibitors prevent off-target toxicity by blocking C/EBPβ phosphorylation at Thr266.

Lowering clavulanate potassium to 21.5 mg/5 mL reduces diarrhea and vomiting while maintaining efficacy against beta-lactamase mediated resistant bacteria.

Hydrophilic ion-exchange resin particles resolve swelling issues in liquid suspensions, enabling stable formulations with controlled drug release.

A nutritional composition blends 1,3-butanediol with beta-hydroxybutyric acid to deliver sustained therapeutic ketosis.